Our Story

Viventis was founded by a team of visionary scientists, oncologists, and AI specialists who recognized the urgent need for innovation in cancer treatment. Inspired by personal experiences and the global cancer crisis, they set out to create a company that merges artificial intelligence with advanced gene-based therapies, ensuring patients receive the best possible care.

Founding Team & Inspiration

Milestones & Breakthroughs

Developed AI models capable of predicting drug efficacy with 80% accuracy.

Successfully conducted preclinical trials for AI-identified cancer drugs.

Launched the first real-time genomic data analysis platform for oncologists.

Partnered with leading hospitals and research centers to integrate AI-driven precision medicine into clinical practice.

Leadership Team

Our leadership team comprises industry experts with decades of experience in oncology, artificial intelligence, and biotechnology. Their combined expertise drives our mission forward, ensuring Viventis remains at the forefront of cancer research and treatment.

Dr. Sandesh Pai
CEO & Co-Founder

A renowned oncologist with 20+ years of experience in precision medicine and cancer research.

Scientific Advisory Board

Comprising top oncologists, biotech researchers, and AI specialists who guide our innovations and clinical applications.

Dr. Hemant Murlidharan
Chief Technology Officer

A pioneer in AI applications for healthcare, leading our machine learning and data analytics division.

Dr. Raksha Gokulnath
Chief Scientific Officer

A leading geneticist specializing in CAR-T therapies and AI-driven drug discovery.

At Viventis, we believe that the future of cancer treatment lies in the seamless integration of AI, genomics, and personalized medicine. Join us on this journey toward a world where cancer is not just treatable but preventable.